巨型肝血管平滑肌脂肪瘤伴包膜下破裂誤診為肝細(xì)胞癌1例報告
摘要:肝血管平滑肌脂肪瘤(HAML)是一種罕見的良性間充質(zhì)腫瘤,多發(fā)于中年女性,由于早期無明顯癥狀,且缺乏特異的影像學(xué)表現(xiàn),因此,診斷難度大,誤診率高。本文報道1例巨型HAML伴包膜下破裂誤診為肝細(xì)胞癌的病例,介紹其病例特點和診治經(jīng)過,期望為此類疾病的診治提供參考。
關(guān)鍵詞:肝腫瘤;血管肌脂瘤;誤診
基金項目:山西醫(yī)科大學(xué)第一醫(yī)院博士基金項目(SYYYRC-2023016)
Rare giant hepatic angiomyolipoma with subcapsular rupture misdiagnosed as hepatocellular carcinoma:A case report
ZHANG Zhiwei 1 ,LIU Feng 2 ,ZHANG Hezhao 3,4a ,WANG Qinying 4b ,SHI Zhiyong 3,4a
1. The First Clinical Medical College of Shanxi Medical University,Taiyuan 030000,China;2. Department of Head and Neck Surgery,Shanxi Cancer Hospital,Shanxi Hospital Affiliated to Cancer Hospital,Chinese Academy of Medical Sciences,Cancer Hospital Affiliated to Shanxi Medical University,Taiyuan 030000,China;3. Institute of Liver Disease,Shanxi Medical University,Taiyuan 030000,China;4. a. Department of Hepatobiliary Surgery,b. Department of Infectious Diseases,The First Hospital of Shanxi Medical University,Taiyuan 030000,China
Corresponding author:SHI Zhiyong,shizhiyong2015@163.com (ORCID:0000-0001-8379-9847)
Abstract:Hepatic angiomyolipoma (HAML) is a rare benign mesenchymal tumor frequently observed in middle-aged women. Due to the absence of prominent symptoms in the early stage and the lack of specific imaging findings,the diagnosis of this disease can be challenging,leading to a high rate of misdiagnosis. This article reports a case of giant HAML with subcapsular rupture that was misdiagnosed as hepatocellular carcinoma and introduces the characteristics of the case and its diagnosis and treatment process,in order to provide a reference for the diagnosis and treatment of this type of disease.
Key words:Liver Neoplasms;Angiomyolipomas;Diagnostic Errors
Research funding:The First Hospital of Shanxi Medical University Doctoral Fund Project (SYYYRC-2023016)
肝 血 管 平 滑 肌 脂 肪 瘤(hepatic angiomyolipoma,HAML)是一種罕見的良性間充質(zhì)腫瘤,通常由血管、平滑肌細(xì)胞和成熟脂肪組織按不同比例組成[1]。(剩余12613字)
- 開拓創(chuàng)新、協(xié)同攻關(guān) 助力人血白...
- 白蛋白生理功能再認(rèn)識...
- 人血白蛋白在肝硬化及其并發(fā)癥中...
- 基因工程人血清白蛋白的研發(fā)與應(yīng)...
- 白蛋白臨床試驗設(shè)計中的統(tǒng)計學(xué)考...
- 肝硬化患者糞菌移植治療指南...
- 肝內(nèi)膽管癌精準(zhǔn)檢測專家共識(2...
- 《2024年國際酒精相關(guān)肝病專...
- 非酒精性脂肪性肝病中醫(yī)/中西醫(yī)...
- 微RNA-128-3p、沉默信...
- 非酒精性脂肪性肝炎小鼠模型肝組...
- 基于代謝組學(xué)探討益氣養(yǎng)陰解毒化...
- 硝酸甘油控制性低中心靜脈壓技術(shù)...
- Go-ichi-ni-san復(fù)...
- 沒食子酸對人肝癌HepG2細(xì)胞...
- 芍藥苷對棕櫚酸誘導(dǎo)的HepG2...
- 美羅培南相關(guān)肝損傷的影響因素及...
- 經(jīng)口膽胰管鏡聯(lián)合內(nèi)鏡逆行胰膽管...
- 基于自動化機器學(xué)習(xí)構(gòu)建膽總管結(jié)...
- 胰腺癌中醫(yī)證候分布規(guī)律及影響因...
- 巨型肝血管平滑肌脂肪瘤伴包膜下...
- 藥物誘導(dǎo)的自身免疫樣肝炎的臨床...
- 氨基酸代謝在自身免疫性肝炎中的...
- 腸道菌群與乙型肝炎肝硬化...
- 終末期肝病模型(MELD)評分...
- 終末期肝病間充質(zhì)干細(xì)胞歸巢能力...
- 腸道菌群及其代謝物在慢加急性肝...
- 肝衰竭腸道屏障損傷與環(huán)鳥苷酸-...
- 經(jīng)內(nèi)鏡逆行胰膽管造影術(shù)后消化道...
- 膽-腸軸在肝內(nèi)膽管癌發(fā)生發(fā)展中...
- 肝內(nèi)膽管癌間質(zhì)-免疫微環(huán)境內(nèi)成...
- Gut|肝臟免疫微環(huán)境失衡驅(qū)動...
- Hepatology Inte...
- Hepatology|多維度解...
- Hepatology Inte...
- Journal of Hepa...
- 《臨床肝膽病雜志》常見異形詞...
- 《臨床肝膽病雜志》推薦使用的規(guī)...
- 《臨床肝膽病雜志》參加2024...
- 《臨床肝膽病雜志》入選“中國科...
- 《臨床肝膽病雜志》2025年1...
- 本期審稿專家...